Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ).

Full DD Report for JAZZ

You must become a subscriber to view this report.


Recent News from (NASDAQ: JAZZ)

Jazz Pharmaceuticals Announces an Informational Webcast for Investors Related to Vyxeos EU Launch
DUBLIN , Sept. 11, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast to provide investors with an overview of the AML treatment landscape in the EU as well as a Vyxeos EU launch overview from the company's executive se...
Source: PR Newswire
Date: September, 11 2018 16:05
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2018 Update
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen's 13F stock portfolio on a quarterly basis. It is based on Viking Global's regulatory 13F Form filed on 08/14/2018. Please visit our Tracking Ole Andreas Halvorsen's Viking Global...
Source: SeekingAlpha
Date: September, 07 2018 07:32
Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences
DUBLIN , Aug. 29, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor conferences.  Wells Fargo Securities Healthcare Conference in Boston, MA on Thursday, S...
Source: PR Newswire
Date: August, 29 2018 16:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-14166.38165.19166.42163.115505,883
2017-07-03156.39156.84158.27155.65248,450
2017-06-30155.74155.50156.70154.50349,438
2017-06-29155.60155.75157.13153.67331,510
2017-06-28154.71155.18157.4499154.36355,755

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1863,240126,52749.9814Short
2018-12-1736,444125,59029.0182Cover
2018-12-1491,262195,65346.6448Short
2018-12-1360,563161,11537.5899Short
2018-12-1254,515169,53332.1560Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on JAZZ.


About Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ)

Logo for Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $9,899,976,922 - 05/17/2018
  • Issue and Outstanding: 59,996,224 - 04/30/2018

 


Recent Filings from (NASDAQ: JAZZ)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 07 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 07 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: July, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 29 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: June, 15 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: June, 15 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: June, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 07 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: June, 05 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 09 2018

 

 


Daily Technical Chart for (NASDAQ: JAZZ)

Daily Technical Chart for (NASDAQ: JAZZ)


Stay tuned for daily updates and more on (NASDAQ: JAZZ)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: JAZZ)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in JAZZ is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of JAZZ and does not buy, sell, or trade any shares of JAZZ. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/